Genomic landscape in small intestine cancer from real-world data (RWD) of clinical genomic testing. Background: Small bowel adenocarcinoma is a rare malignancy with limited data to support the choice ...
Phase II trials are used to show sufficient preliminary activity of a new treatment (in single-arm designs or randomized screening designs) or to select among treatments with demonstrated activity (in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results